Colchicine for epidermolysis bullosa acquisita

Journal of the American Academy of Dermatology

Volumn 34, Issue 5 I, 1996, Pages 781-784

  Cunningham, Bari B ^b   Kirchmann, Tin Tin T ^a   Woodley, David ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; COLCHICINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; PREDNISONE; SULFAPYRIDINE;

ADULT; AGED; ARTICLE; BLISTER; CASE REPORT; DOSE RESPONSE; DRUG EFFICACY; EPIDERMOLYSIS BULLOSA ACQUISITA; FEMALE; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0029993454     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(96)90013-4     Document Type: Article

References (15)

1. Berbis Privat Y. Interet de la colchicine dans le traitement de l'epidermolyse bulleuse acquise. Ann Dermatol Venereol 1989;116:301-7.
2. Lapiere JC, Woodley DT, Parente MG, et al. Epitope mapping of type VII collagen identification of discrete peptide sequences recognizing by sera from patients with acquired epidermolysis bullosa. J Clin Invest 1993;92: 1831-9.
3. Roenigk HH, Ryan JG, Berfield WF, et al. Epidermolysis bullosa acquisita: report of three cases and review of all published cases. Arch Dermatol 1971;103:1-10.
4. Crow LL, Finkle JP, Gammon WR, et al. Clearing of epidermolysis bullosa acquisita with cyclosporine. J AM ACAD DERMATOL 1988;19:937-42.
5. Gammon WR, Briggaman RA, Woodley DT, et al. Epidermolysis bullosa acquisita - a pemphigoid-like disease. J AM ACAD DERMATOL 1984;11:820-32.
6. Dahl MGC. Epidermolysis bullosa acquisita: a sign of cicatricial pemphigoid. Br J Dermatol 1979;101:475-84.
7. Gammon WR, Briggaman RA, Inman AO, et al. Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by direct immunofluorescence on 1.0 M sodium chloride separated skin. J Invest Dermatol 1984; 82:139-44.
8. Malkinson F. Colchicine: new uses of an old drug. Arch Dermatol 1982;118:453-7.
9. Olmsted JB, Borisy GGG. Microtubules. Ann Rev Biochem 1973;42:507-40.
10. Ehrenfeld M, Levy M, Bar Eli M, et al. Effect of colchicine on polymorphonuclear leucocyte chemotaxis in human volunteers. J Clin Pharmacol 1980;10:297-300.
11. Gammon WR, Inman AO, Wheeler CE. Differences in complement-dependent chemotatic activity generated by bullous pemphigoid and epidermolysis bullosa acquisita immune complexes: demonstration by leukocytic attachment and organ culture methods. J Invest Dermatol 1984; 83:57-61.
12. Rudolph SA, Greengard P, Malawista SE. Effect of colchicine on cyclic AMP levels in human leukocytes. Proc Natl Acad Sci U S A 1977;74:3404-8.
13. Antoine JC, Maurice M, Feldmann G, et al. In vivo and in vitro effects of colchicine and vinblastine on the secretory process of antibody-producing cells. J Immunol 1980; 125:1939-49.
14. Mekori YA, Chowers Y, Drucker I, et al. Inhibition of delayed hypersensitivity reaction by colchicine: II. colchicine inhibits interferon-gamma induced expression of HLA-DR on gut epithelial cell line. Clin Exp Immunol 1989;78:230-2.
15. Bauer EA, Valle KJ. Colchicine-induced modulation of collagenase in human skin fibroblast cultures: I. stimulation of enzyme synthesis in normal cells. J Invest Dermatol 1982;79:398-402.